This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ROKA (ROKA) (ROKA) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About (ROKA) Stock (NASDAQ:ROKA) 30 days 90 days 365 days Advanced Chart Get (ROKA) alerts:Sign Up Key Stats Today's Range$0.65▼$0.6950-Day Range N/A52-Week Range$0.60▼$6.20Volume242,292 shsAverage Volume371,374 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSorrento Tech, Inc., formerly Roka Bioscience, Inc., is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.Read More… Receive ROKA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ROKA) and its competitors with MarketBeat's FREE daily newsletter. Email Address ROKA Stock News HeadlinesFrom Balika Vadhu's Anandi to bride-to-be: Avika Gor's fairytale rokaJune 14, 2025 | msn.comMr India Fame Varun Verma Gets Roka-Fied; here's an EXCLUSIVE Peek!June 12, 2025 | msn.comWhat a “Mar-a-Lago Accord” could mean for the US dollar.25-Year Market Vet Issues Urgent Dollar Warning He's spent 25 years tracking the flow of global money - now he's coming forward with an urgent warning about a D.C. plan to deliberately crash the dollar. If it succeeds, you could see 40% of your savings vanish overnight. This free video explains why and gives you four important steps to take immediately.June 20, 2025 | Stansberry Research (Ad)Avika Gor Engaged To Boyfriend Milind Chandwani. First Pics From Roka Ceremony OutJune 11, 2025 | msn.com27 of the best Japanese restaurants to book in RiyadhJune 9, 2025 | msn.comHousefull 2 actor Shazahn Padamsee marries businessman Ashish Kanakia in two-day affair. See picsJune 6, 2025 | msn.com110 fall ill after consuming food at ritual in RolpaJune 1, 2025 | msn.com8 great Dubai restaurant deals to dine at the city’s top restaurants for lessMay 29, 2025 | msn.comSee More Headlines ROKA Stock Analysis - Frequently Asked Questions How were (ROKA)'s earnings last quarter? (ROKA) (NASDAQ:ROKA) announced its quarterly earnings data on Thursday, May, 11th. The medical research company reported ($1.53) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.19) by $0.34. The medical research company had revenue of $2.04 million for the quarter. What other stocks do shareholders of (ROKA) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (ROKA) investors own include Credit Suisse High Yield Bond Fund (DHY), Western Asset High Income Fund II (HIX), Pimco Corporate & Income Opportunity Fund (PTY), ASML (ASML), Corbus Pharmaceuticals (CRBP), Stag Industrial (STAG) and Twitter (TWTR). Company Calendar Last Earnings5/11/2017Today6/20/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ROKA CIK1472343 Webwww.rokabio.com Phone+1-908-6054700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:ROKA) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredTrump Made a Deal. Your Retirement Could Still Be in Danger.America is still barreling toward a financial cliff. This isn't political. It's mathematical. And no trade ...Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ROKA) Please log in to your account or sign up in order to add this asset to your watchlist. Share (ROKA) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.